DETERMINING CATHETER-TIP 3D LOCATION AND ORIENTATION USING FLUOROSCOPY AND IMPEDANCE MEASUREMENTS
20200093397 ยท 2020-03-26
Assignee
Inventors
- Jasbir Sra (Pewaukee, WI, US)
- James Baker (Woodbury, MN, US)
- Jeffrey Burrell (Coon Rapids, MN, US)
- Mark Palma (Fitchburg, WI, US)
- Barry Belanger (Chenequa, WI, US)
Cpc classification
A61B5/7285
HUMAN NECESSITIES
G06V40/15
PHYSICS
A61B6/5294
HUMAN NECESSITIES
A61B5/349
HUMAN NECESSITIES
A61B6/12
HUMAN NECESSITIES
A61B34/20
HUMAN NECESSITIES
A61B2017/00699
HUMAN NECESSITIES
A61B6/5205
HUMAN NECESSITIES
A61B6/541
HUMAN NECESSITIES
A61B2017/00703
HUMAN NECESSITIES
A61B2090/367
HUMAN NECESSITIES
A61B2090/3966
HUMAN NECESSITIES
International classification
A61B5/06
HUMAN NECESSITIES
A61B34/20
HUMAN NECESSITIES
Abstract
A method for determining the 3D location of a catheter distal end portion in a patient's body, the distal end portion including an electrode, the method comprising: (a) placing first and second body-surface patches on the patient in positions such that body region of interest is therebetween; (b) driving an alternating current between the patches; (c) measuring the voltage at the electrode and substantially contemporaneously capturing a 2D fluoroscopic image of the region of interest; and (d) determining the 3D location of the catheter distal end portion from the image and the measured voltage. A primary application of this method is 3D navigation during cardiac interventional procedures.
Claims
1. A method for determining the 3D location and orientation of a catheter tip in a patient's cardiac chamber, the catheter having a distal end portion including two or more electrodes adjacent thereto, the method comprising: placing first and second body-surface patches on the patient in locations such that the cardiac chamber is therebetween, the first and second body-surface electrodes defining a depth dimension; driving an alternating current between the patches; measuring the voltage at the electrodes and substantially contemporaneously capturing a 2D fluoroscopic image of the cardiac chamber; and determining the 3D location and orientation of the catheter distal end portion from the image and the measured voltages.
2. The method of claim 1 further including placing a body-surface reference patch on the patient, the voltages being measured with respect to the reference patch.
3. The method of claim 1 wherein the alternating current has a constant peak-to-peak amplitude.
4. The method of claim 1 wherein the first body-surface patch is positioned on the patient's chest, and the second body-surface patch is positioned on the patient's back.
5. The method of claim 1 wherein the step of measuring voltage includes using synchronous detection.
6. The method of claim 5 wherein the step of measuring voltage includes applying a Goertzel filter to the voltage.
7. The method of claim 6 wherein the output of the Goertzel filter is a complex number having real and imaginary parts, and the output is transformed into a real number by computing the square root of the sum of the squares of the real and imaginary parts.
8. The method of claim 7 wherein a window function is applied to the voltage prior to applying the Goertzel filter.
9. The method of claim 8 wherein the window function is a Blackman window.
10. The method of claim 1 further including correcting for changes in fluoroscopic table position and orientation and C-arm angle.
11. The method of claim 1 further including calibration steps comprising: locating one electrode of the catheter distal end portion at two or more calibration locations within the cardiac chamber, some of the calibration locations being separated from the other calibration locations along the depth dimension; determining spatial coordinates of the one electrode in each calibration location using only fluoroscopy; measuring the voltages at the one electrode at each calibration location; and computing a depth-versus-voltage relationship therefrom.
12. The method of claim 11 wherein determining the spatial coordinates of the one electrode includes capturing two 2D fluoroscopic images of the cardiac chamber from different angles and applying back-projection calculations thereto.
13. The method of claim 11 wherein computing the depth-versus-voltage relationship includes determining a linear regression relationship between the voltages and the corresponding depths of the calibration locations.
14. The method of claim 11 wherein determining the spatial coordinates of the one electrode includes the steps of: capturing a stream of digitized 2D images of the cardiac chamber from a single angle; detecting an image of the one electrode in a subset of the digital 2D images; applying to the digital 2D images calculations which preserve original pixel intensity values and permit statistical calculations thereon, using a plurality of unfiltered raw-data cross-sectional intensity profiles and statistically combining the profiles to estimate image dimensions, thereby to measure the electrode image; applying conical projection and radial elongation corrections to the image measurements; and calculating the spatial coordinates of the electrode from the corrected 2D image measurements.
15. The method of claim 1 further including placing a body-surface impedance-monitoring patch on the patient, measuring the voltage thereon, and monitoring bulk impedance of the patient.
16. The method of claim 15 further including the step of recalibration when a change in the bulk impedance exceeds a threshold.
17. The method of claim 1 wherein measuring the voltages and capturing the 2D fluoroscopic images are gated by respiratory phase.
18. The method of claim 1 wherein measuring the voltages and capturing the 2D fluoroscopic images are gated by cardiac phase.
19. The method of claim 18 wherein measuring the voltages and capturing the 2D fluoroscopic images are gated by respiratory phase.
20. The method of claim 1 wherein one of the two or more electrodes is an ablation electrode, and the ablation electrode is electrically-isolated from voltage measurement circuitry during ablation.
21. The method of claim 1 further including capturing ECG/EGM signals from the patient and time-marking the measured voltages, the captured 2D fluoroscopic image, and the ECG/EGM signals with a common timing signal.
22. The method of claim 21 further including time-marking a respiration signal with the common timing signal.
23. A method for determining the 3D location of a catheter distal end in a patient's body, the distal end including an electrode, the method comprising: placing first and second body-surface patches on the patient in positions such that body region of interest is therebetween; driving an alternating current between the patches; measuring the voltage at the electrode and substantially contemporaneously capturing a 2D fluoroscopic image of the region of interest; and determining the 3D location of the catheter distal end from the image and the measured voltage.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0048]
[0049] A programmable computer 16 configured and programmed to carry out the steps of embodiment 10 receives the aforementioned data and signals and provides numerical and graphical information to at least a visual display 18 which presents to the electrocardiologist the 3D and other pertinent information by which to carry out a cardiac interventional procedure such as cardiac ablation.
[0050] Other data is available to computer 16 such as a C-arm angle .sub.C and fluoroscopic table position and/or orientation D.sub.T from fluoroscopic system 12 indicating the position/orientation of the X-ray beam relative to a patient, catheter specifications such as catheter type/model and geometric data describing catheter tip 28, and calibration data from a calibration process 20. Fluoroscopic system 12 may also provide signals containing table data D.sub.T which provides information on the position and orientation of the fluoroscope table (not shown). Calibration process 20 is indicated as a separate block in
[0051] Note that in embodiment 10, many of the signals indicated may be digitized signals. Herein, many analog and digital signals are indicated for simplicity as functions of time t (e.g., f(t)) rather than using a time index for streams of digital signals. Digital signals will be explicitly indicated as such in their descriptions. For example, as will be described later, catheter electrode signal V.sub.C(t) is an analog signal captured by an electrode while V(t) is a digital stream of values output from single-axis impedance system 14. Fluoroscopic image stream IM(t) is a stream of two-dimensional arrays of digital image-intensity values captured by an X-ray detector D within fluoroscopic system 12.
[0052] As described above, the inventive hybrid fluoroscopic/impedance navigational method exploits the high geometric accuracy of fluoroscopic images in the two dimensions of the plane of X-ray detector D while rapidly capturing the third spatial dimension (depth) in a fashion which limits the X-ray exposure of a patient, combining 2D fluoroscopy to capture two spatial dimensions and measurement of the electrical impedance of and within a patient's torso 22 (see
[0053]
[0054] In
[0055] By comparison, the aforementioned system for determining 3D catheter location and orientation using only 2D fluoroscopy disclosed in the Sra et al. determines d.sub.1 from writing the above relationship as d.sub.1=d.sub.2.Math.v/v.sub.I. The calculation of depth d.sub.1 of catheter tip 28 from its width v.sub.I in image I.sub.D is very sensitive to the determination of width v.sub.I. For a 7 French catheter (2.33 mm diameter) and typical imaging geometry for fluoroscopic system 12, achieving a depth accuracy of approximately +4 mm requires measurement accuracy of width v.sub.I of approximately 0.02 mm. Such measurement accuracy is subpixel, and in order to achieve such subpixel accuracy using width measurement from a pair of edge points in image I.sub.D, the error required for each edge point is 0.02 mm/2=0.01 mm. The fraction of a pixel corresponding to a precision of 0.01 mm is 0.01/0.2=0.05 pixels or about 1/20th of a pixel. Therefore, in order to achieve this accuracy of depth d.sub.1, the Sra et al. approach incorporates statistical calculations of many width measurements and the use of multiple images.
[0056]
[0057] Referring again to
[0058]
[0059]
[0060] It should be noted that although single-axis impedance system 14 is indeed an electrical impedance-based system, all of the measurements being made are of voltages and the values of the various impedances involved need not be determined. (In the model of
[0061] It should also be noted that an alternating current is employed to minimize the nonlinear effects of the interface between electrodes and the conductive fluids in a human body. Voltage measurements are peak-value measurements.
[0062] Electrical behavior of the simplified circuit model of
[0063] Referring to both
z.sub.C=[(z.sub.40z.sub.42)/(V.sub.40V.sub.42)].Math.(V.sub.CV.sub.42)+z.sub.42.
[0064] Rewriting this depth-versus-voltage relationship results in a relationship: z.sub.C=A.Math.V.sub.C+z.sub.42 where A is a scalar-valued scale factor in units of mm/mv (millimeters/millivolt). Note that with constant peak-to-peak current I(t), impedance is proportional to voltage so that scale factor A can also be determined in units of millimeters/ohm (mm/).
[0065] In the description above, the z-coordinates of points 40 and 42 have been assumed to be known in the calculations of scale factor A and depth z.sub.C. These values are known as a result of a calibration method in which the z-coordinates of an electrode (e.g., electrode E.sub.2) are determined by locating electrode E.sub.2 at two or more calibration locations within cardiac chamber 26 at which these calibration locations are separated from the other calibration locations along z-dimension. (Such use of electrode E.sub.2 for this and in later descriptions is exemplary and is not intended to be limiting; any electrode may be used.) Then fluoroscopic system 12 is used to determine the spatial coordinates of electrode E.sub.2 in each calibration location while substantially contemporaneously capturing voltages at electrode E.sub.2. This information is then used to compute a depth-versus-voltage relationship as described above.
[0066] Three approaches to calibration are disclosed in this document. The first of these has already been described above with respect to
[0067] A second approach to calibration is illustrated in
[0068] During calibration, determination of the 3D location of an electrode using only fluoroscopy may be done in at least two ways. A first method includes determining the spatial coordinates (x,y,z) of electrode E.sub.2 at two locations in cardiac chamber 26 by capturing for each of the two points two 2D fluoroscopic images of cardiac chamber 26 (and electrode E.sub.2) from different angles and applying back-projection calculations thereto. The details of back-projection calculations are well-known to those skilled in the area of mathematics and will not be described here. Nevertheless, by way of illustration,
[0069] Referring again to
[0070] Following this capture of two fluoroscopic images of electrode E.sub.2 from different angles, electrode E.sub.2 is moved to point 42 and two fluoroscopic images of electrode E.sub.2 at point 42 are captured from different angles, this time first with fluoroscopic system 12 configured at source S.sub.2 and detector D.sub.2 and then at source S.sub.1 and detector D.sub.1. Now, with x,y-coordinate pairs x.sub.1,y.sub.1 and x.sub.2,y.sub.2 measured for each of points 40 and 42, there is sufficient data to determine the 3D coordinates of both points 40 and 42 using back-projection calculations.
[0071] A voltage measurement is taken substantially contemporaneously with the capture of each of the images such that voltage measurements are known as best as possible at the times of image capture. Also, gating with cardiac phase and/or with respiratory phase may be employed so that not only blurring within the fluoroscopic images is minimized but so that, as best as possible, the 3D coordinates of each point 40 (and 42) when taken at different times, are the same from different C-arm angles.
[0072] An alternative method for determining the 3D location of an electrode during calibration is described in detail in the aforementioned Sra et al. reference. This alternative method includes the steps of: (a) capturing a stream of digitized 2D images of cardiac chamber 26 from a single C-arm angle .sub.C; (b) detecting an image of electrode E.sub.2 in a subset of the digital 2D images; (c) applying to the digital 2D images calculations which preserve original pixel intensity values and permit statistical calculations thereon, using a plurality of unfiltered raw-data cross-sectional intensity profiles and statistically combining the profiles to estimate image dimensions, thereby to measure the image of electrode E.sub.2; (d) applying conical projection and radial elongation corrections to the image measurements; and (e) calculating the spatial coordinates of the electrode from the corrected 2D image measurements. As stated above, the use of electrode E.sub.2 is exemplary in this description and not intended to be limiting. Also note that initialization of the method described in the Sra et al. reference requires a back-projection process prior to the above operations.
[0073] In this alternative method, the C-arm angle .sub.C of fluoroscopic system 12 remains unchanged during calibration, and the 3D location of electrode E.sub.2 is determined at two or more positions within cardiac chamber 26. Calibration may be carried out as illustrated in
[0074] Again as above, a voltage measurement is taken substantially contemporaneously with the capture of each of the images such that voltage measurements are known as best as possible at the times of image capture, and gating with cardiac phase and/or with respiratory phase may be employed.
[0075]
[0076] During normal operation of method embodiment 10, in order to determine the orientation of catheter tip 28 as well as its location, voltage measurements are made at more than one electrode on catheter tip 28. For example, voltages at electrodes E.sub.1, E.sub.2, E.sub.3, and E.sub.4 may all be measured, and since the z-coordinate for each of these electrodes is found from the depth-versus-voltage relationship determined during calibration and the x,y-coordinates of each electrode is found from fluoroscopic images captured substantially contemporaneously with the voltage measurements, well-known trigonometric relationships may be used to determine orientation of catheter tip 28.
[0077] As described above, the C-arm of fluoroscopic system 12 may be rotated into positions other than the AP (anterior/posterior) or vertical position, such orientation being as illustrated in
[0078] The computations required for such coordinate transformations are well-known to those skilled in mathematics and need not be described detail herein. For each determination of a 3D location of an electrode on catheter tip 28, the known quantities are: (1) values for x and yin the plane of detector D, (2) angle .sub.C of the C-arm of fluoroscopic system 12, (3) position and orientation of the fluoroscopic table as provided by table data D.sub.T, and (4) a value for z in the coordinate system aligned with the AP patient position. Many currently-available fluoroscopic systems such as fluoroscopic system 12 provide signals with table data D.sub.T readily available to computer 16 for such computations, and when fluoroscopic table position and/or orientation D.sub.T are adjusted and when C-arm angle .sub.C is changed, appropriate coordinate transformations are updated. After such coordinate transformation, the 3D location for the electrode on catheter tip 28 is known. Measurements of more than one electrode on catheter tip 28 also then yield the 3D orientation of catheter tip 28.
[0079]
[0080] In the embodiment of
[0081] Driving current I(t) is generated by direct digital synthesis process 84 which produces a digitally-synthesized sinusoid of highly accurate frequency and phase. Such sinusoidal signal is then converted to an analog signal by an analog-to-digital converter 86 and buffered and filtered in buffer amplifiers 88 to smooth out the stair-step portion of the synthesized sinusoid. Finally, the filtered output from buffer amplifiers 88 passes through an isolation transformer 90 and two resistive loads 92 before being applied to torso 22 through body-surface patches 30 and 32. The result of driving current I(t) being applied across torso 22 is that due to the distribution of electrical impedance within torso 22 including cardiac chamber 26, a catheter voltage signal V.sub.C(t) is created on an electrode (e.g., E.sub.1, E.sub.2, E.sub.3, or E.sub.4) on catheter tip 28 as described above with respect to
[0082] Catheter voltage signal V.sub.C(t) is filtered in a filter 94 which provides low- and high-pass filtering and protection to limit energy from cardiac ablation and to permit recovery from pacing and defibrillation pulses. (As shown in
[0083] Output from filter 94 is buffered by buffer amplifier 96, passes through a low-pass filter (set at 10 kHz, such setting not intended to be limiting) to reduce signal noise, and is then converted to a digital stream of voltage values in an analog-to-digital converter 98 as input to a Blackman-windowed Goertzel filter 100 which includes Blackman window function 102 and Goertzel filter 104. Filter embodiment 100 evaluates the digital voltage from A/D converter 98 using synchronous detection. The advantage of synchronous detection is its ability to extract low-level signals from signals which may contain a significant amount of noise. The output from A/D converter 98 is a stream of interim digital voltage values v(t.sub.i) which in the example being illustrated herein, is a stream of voltage values sampled 64,000 times per second. (This sampling rate is not intended to be limiting; other appropriate sampling rates are possible.)
[0084] Filter 100 is configured to measure the signal at a specific target frequency while to a great degree ignoring portions of the signal at other frequencies, thereby measuring that portion of signal v(t.sub.i) which is of most importance. Blackman window function 102 is applied as shown in section 9-3 to each of the samples v(t.sub.i) in a block. Blackman-windowed Goertzel filter 100 is one example of applying synchronous detection and is not intended to be limiting; other configurations are within the scope of the present invention. For example, other window functions other than Blackman filter 102 may be combined with Goertzel filter 104, and other substantially different approaches to synchronous detection may also be employed.
[0085]
[0086] Section 9-3 describes the application of Blackman window 102 to stream of interim digital voltage values v(t.sub.i) generated by A/D converter 98. Blackman window 102 is applied to the N interim digital voltage signal values in the block of data. The use of window functions is well-known to those skilled in the art of digital filtering, and Blackman window 102 is among the set of window functions often used in the design of digital filters. The Blackman window parameter values shown in section 9-3 are close approximations to those for an exact Blackman filter. Values given here are not intended to be limiting; other sets of parameters are within the scope of the present invention.
[0087] Section 9-4 of
[0088] Section 9-5 also includes a plot 103 which shows the results of the calculations as presented in
[0089]
[0090] As illustrated in embodiment 60, timing signal T(t) is an input to both a gating module 16G and synchronization module 16S and is thus the common reference for every signal (and image) in embodiment 60, including ECG/EGM signals C(t) and respiratory signal R(t) which in embodiment 60 are inputs to gating module 16G. The source of timing signal T(t) may be computer 16 or an external device such as equipment (not shown) used to capture the ECG/EGM signals C(t). Such external equipment is well-known in the field of cardiology and need not be described herein. In all cases, timing signal T(t) is essentially the master time to which all signals are referenced.
[0091] As an example to illustrate the role of time-marking of the various signals involved in the method, fluoroscopic system 12 may capture 2D images IM(t) at the rate of 7.5 fps (frames per second) or every 133 ms (milliseconds); single-axis impedance system 14 may output voltages V(t) every 10 ms, and ECG/EGM signals C(t) may stream at the rate of 1,000 sps (sample per second). In addition, respiration signals R(t) may stream at yet a different rate. Time-marking all such signals based on common timing signal T(t) assures that each of the signals is understood in its proper relationship to all of the other signals. The specific frequencies in this example set of frequencies are not intended to be limiting in any way.
[0092] In embodiment 60, in addition to establishing the substantially contemporaneous voltage measurements V(t) and image captures IM(t), fluoroscopic images IM(t) are gated with respect to both cardiac and respiratory phase to reduce motion within the fluoroscopic images which are processed to obtain x,y coordinates within the plane of X-ray detector D. Gating can be achieved by selecting images from within the stream of captured images IM(t) and/or by selectively capturing images at times when it is anticipated that gating criteria are satisfied based on cardiac signals C(t) and respiratory signal R(t).
[0093]
[0094]
[0095] Referring again to
[0096] Referring again to
[0097]
[0098]
[0099] Bulk impedance is measured by monitoring the voltage at body-surface impedance patch 38 in just the same way as measurements of catheter electrode voltages V.sub.C(t). In fact, in
[0100] As bulk impedance changes over time and such change exceeds a bulk-impedance threshold T.sub.BI, the inventive method recalibrates the scale factor A. This is illustrated as the difference between peak inspiration impedance values I.sub.P1 and I.sub.P2 reaching the threshold value T.sub.BI. Threshold T.sub.BI may be a percentage (e.g., 10%) of the bulk impedance value I.sub.P1 measured after the most recent calibration. Such threshold value determination is not intended to be limiting; other indications that recalibration may be beneficial are within the scope of the present invention.
[0101] The present inventive method has a number of significant advantages when compared with current navigational systems. When compared to systems such as the CARTO and EnSite NavX systems which use both magnetics and electrical impedance, in addition to the clear advantage of the inherent 2D accuracy of fluoroscopic images, there are a number of advantages which single-axis impedance system 14 contributes to the present inventive method. Among these are the following: (1) Single-axis impedance system 14 is easier to compensate for measurement anomalies than multi-axis impedance systems. (2) AP-oriented single-axis current path 34 (same reference number as electric field 34) is less impacted by the lungs than lateral current paths of multi-axis impedance systems. (3) AP-oriented single-axis current path 34 is the shortest path and has the lowest impedance of the three-axes across torso 22; for error represented as a percentage of the total impedance, a percentage of a smaller number results in smaller error. (4) Changes in bulk impedance over time due to drift is proportional to total impedance, resulting in lower absolute drift for the lower total impedance of the shortest axis. (5) In three-axis impedance systems, the problematic axis is the neck-to-leg axis because of the magnitude of the impedance and the propensity for movement of patches on parts of the body that can move changing the current path. Single-axis impedance system 14 avoids this axis. (6) Single-axis impedance system 14 requires fewer body-surface patches and shorter setup time, and therefore has less opportunity for setup errors and patches becoming loose.
[0102] When compared in a cardiac mapping procedure to the Navik 3D system developed by APN Health, LLC (described in the Sra et al. reference), it is estimated that the present inventive hybrid fluoro/impedance approach is five times more efficient than the Navik 3D system in producing map points for a given amount of patient radiation exposure. Such combination of low radiation exposure, accuracy, and the attendant rapid speed of generating mapping points provides an important advance in medical navigational technology. For the clinical objective of generating a certain number of map points, the present inventive hybrid fluoro/single-axis impedance navigational method for determining the 3D location and orientation of a catheter tip in a patient's cardiac chamber would require one-fifth the radiation required by the Navik 3D system.
[0103] During operation of the hybrid fluoro/single-axis impedance system, the inherent accuracy of the fluoroscopic images is used to calibrate the impedance using points at the top and bottom of a chamber rather than using the body-surface electrodes of conventional 3D impedance systems. In this way, the inventive method avoids errors introduced by non-homogeneous tissue between the body-surface patches and the cardiac chamber. Using the inventive methods of calibration provides better performance because the impedance values are pegged at or near the boundaries of the chamber and have improved linearity within the chamber because the tissue medium (blood) is relatively uniform from an electric field perspective.
[0104] Finally, and maybe most significantly, the overall speed with which a cardiac map may be generated provides a dramatic improvement. With single-axis impedance data being acquired very rapidly, it is possible to essentially generate a map point at a large fraction of the frames during cardiac diastole because the x,y coordinates of a catheter tip can be reliably determined from a single frame. Thus, extremely rapid cardiac mapping is possible using the present inventive method.
[0105] While the principles of this invention have been described in connection with specific embodiments, it should be understood clearly that these descriptions are made only by way of example and are not intended to limit the scope of the invention.